Answers are grounded in this paper and cite their sources.
A single infusion of 1000 mg rituximab significantly delays the development of arthritis in subjects at risk of developing RA, providing evidence for the pathogenetic role of B cells in the earliest, prearthritis stage of autoantibody positive RA.
No takes yet. Share an insight, caveat, or question.
Gerlag et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: